Clinical Trial Results: Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

A crossover pharmacokinetics study comparing subcutaneous versus intravenous administration of a novel furosemide regimen in adults with chronic heart failure, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Furosemide (Regimen, subcutaneous vs intravenous) (furosemide)

Snippet

Sponsor: SQ Innovation, Inc. | Conditions: Heart Failure | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-15